Lung Cancer
New findings from University of Texas, M. D. Anderson Cancer Center in the area of lung cancer published
Published in Cancer Weekly, June 1st, 2010
New research, 'Phase 2 study of carboplatin, docetaxel, and bevacizumab as frontline treatment for advanced nonsmall-cell lung cancer,' is the subject of a report. "Bevacizumab has recently been demonstrated to prolong overall survival when added to carboplatin and paclitaxel for chemotherapy-naive patients with nonsquamous nonsmall-cell lung cancer (NSCLC). However, the effects of combining bevacizumab with other standard, front-line, platinum-based doublets have not been extensively explored," investigators in the United States report.
"We designed this single treatment arm, phase 2 trial to determine whether the combination of carboplatin, docetaxel, and bevacizumab...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2010-06-01)
More Articles from Cancer Weekly
- Prostate Cancer
Scientists find protein spurs spread of prostate cancer - Pancreatic Cancer
Researchers from University of Nebraska Medical Center detail new studies and findings in the area of pancreatic cancer - Colon Cancer
Data on colon cancer published by researchers at University of North Carolina, Department of Epidemiology - Prostate Cancer
Reports outline prostate cancer research from University of Washington, Department of Urology - Bowel Cancer
Investigators at University of Warwick release new data on bowel cancer - Prostate Cancer
Findings from University of Colorado in prostate cancer reported - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
